Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Attention Deficit Hyperactivity Disorder (ADHD) - Adults (Dexamfetamine sulfate - Attention Deficit Hyperactivity Disorder (ADHD) - Adults)

Records returned : 7 (on 04 Sep 2025 at 04:57:44). Return to search results for ' Attention Deficit Hyperactivity Disorder (ADHD) - Adults '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off Label

Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

SPC

View the treatment summary for {padindicationname} on https://www.medicines.org.uk

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Dexamfetamine sulfate

Drug:

Dexamfetamine sulfate

Indication :

Attention Deficit Hyperactivity Disorder (ADHD) - Adults

Status :

Amber

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Important

Adult ADHD - to be diagnosed, initiated and stabilised on ADHD medication by a SABP specialist before shared-care can be requested.

Patients transitioning from children's services can continue to be managed under existing arrangements

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

SPC

2. Atomoxetine hydrochloride

Drug:

Atomoxetine hydrochloride

Indication :

Attention Deficit Hyperactivity Disorder (ADHD) - Adults

Status :

Amber

Formulations :

Capsules
Oral solution

Restrictions / Comments:

Important

Adult ADHD - to be diagnosed, initiated and stabilised on ADHD medication by a SABP specialist before shared-care can be requested.

Patients transitioning from children's services can continue to be managed under existing arrangements

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

SPC

3. Lisdexamfetamine

Drug:

Lisdexamfetamine

Indication :

Attention Deficit Hyperactivity Disorder (ADHD) - Adults

Status :

Amber

Formulations :

Capsules

Restrictions / Comments:

Important

Adult ADHD - to be diagnosed, initiated and stabilised on ADHD medication by a SABP specialist before shared-care can be requested.

Patients transitioning from children's services can continue to be managed under existing arrangements

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

SPC

4. Methylphenidate hydrochloride

Drug:

Methylphenidate hydrochloride

Indication :

Attention Deficit Hyperactivity Disorder (ADHD) - Adults

Status :

Amber

Formulations :

Modified release tablets

Restrictions / Comments:

Important

18mg, 27mg, 36mg, 54mg: Prescribe by brand - use the branded-generic with the lowest acquisition cost

Adult ADHD - to be diagnosed, initiated and stabilised on ADHD medication by a SABP specialist before shared-care can be requested.

Patients transitioning from children's services can continue to be managed under existing arrangements

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

Off Label

SPC

5. Methylphenidate hydrochloride

Drug:

Methylphenidate hydrochloride

Indication :

Attention Deficit Hyperactivity Disorder (ADHD) - Adults

Status :

Amber

Formulations :

Immediate release tablets
Oral solution

Restrictions / Comments:

Important

Adult ADHD - to be diagnosed, initiated and stabilised on ADHD medication by a SABP specialist before shared-care can be requested.

Patients transitioning from children's services can continue to be managed under existing arrangements.

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

Off Label

SPC

6. Methylphenidate hydrochloride

Drug:

Methylphenidate hydrochloride

Indication :

Attention Deficit Hyperactivity Disorder (ADHD) - Adults

Status :

Amber

Formulations :

Modified release capsules

Restrictions / Comments:

Important

Adult ADHD - to be diagnosed, initiated and stabilised on ADHD medication by a SABP specialist before shared-care can be requested.

Patients transitioning from children's services can continue to be managed under existing arrangements

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

NICE

Off Label

SPC

7. Guanfacine

Drug:

Guanfacine

Indication :

Attention Deficit Hyperactivity Disorder (ADHD) - Adults

Status :

See narrative

Formulations :

Modified release tablets

Restrictions / Comments:

Important

Guanfacine for use in adult patients with ADHD (that have not transferred from children’s service on the medication), has not yet been assessed for formulary status.

National shared care documents are being considered by Surrey & Borders Partnership NHS Foundation Trust for implementation over the next few months through APC.

Adult patients currently being prescribed guanfacine in primary care can continue on treatment until they and their prescriber or specialist consider it appropriate to stop.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

Off Label